McKesson Sheds Nearly All Claims in Suit Over MRI Contrast Dye

Distributor McKesson Corp. won dismissal of nearly all of a Louisiana man’s suit alleging he developed serious injuries from a gadolinium-based contrast dye used in MRIs, as a federal court in Louisiana ruled most claims preempted.

Rickey Lewis alleged he received Omniscan injections in connection with several magnetic resonance imaging scans. Soon after that, he allegedly developed Gadolinium Deposition Disease, with symptoms including confusion, fatigue, and difficult and painful movement.

Lewis alleged he wouldn’t have received the gadolinium-based contrast agent had he and/or his healthcare provider been warned of the risk.

But McKesson couldn’t have changed the federally approved product ...